Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

C4 Therapeutics (CCCC) Return on Invested Capital: 2020

  • C4 Therapeutics' Return on Invested Capital was N/A to -0.89% in Q4 2020 from the same period last year, while for Dec 2020 it was -0.89%, marking a year-over-year change of. This contributed to the annual value of -0.71% for FY2020, which is N/A change from last year.
  • Latest data reveals that C4 Therapeutics reported Return on Invested Capital of -0.89% as of Q4 2020, which was down 343.15% from 0.37% recorded in Q3 2020.
  • Over the past 5 years, C4 Therapeutics' Return on Invested Capital peaked at 0.37% during Q3 2020, and registered a low of -0.89% during Q4 2020.
  • Its 1-year average for Return on Invested Capital is -0.26%, with a median of -0.26% in 2020.